▶ 調査レポート

痔治療用デバイスの世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Hemorrhoid Treatment Devices Market (Device: Band Ligators, Sclerotherapy Injectors, Infrared Coagulators, Bipolar Probes, Cryotherapy Devices, Hemorrhoid Laser Probes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが調査・発行した産業分析レポートです。痔治療用デバイスの世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測 / Hemorrhoid Treatment Devices Market (Device: Band Ligators, Sclerotherapy Injectors, Infrared Coagulators, Bipolar Probes, Cryotherapy Devices, Hemorrhoid Laser Probes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2211A099資料のイメージです。• レポートコード:MRC2211A099
• 出版社/出版日:Transparency Market Research / 2022年9月
• レポート形態:英文、PDF、183ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
トレンスペアレンシーマーケットリサーチ社の当調査レポートでは、世界の痔治療用デバイス市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、デバイス別(バンド結紮装置、硬化療法用インジェクター、赤外線凝固装置、バイポーラプローブ、その他)分析、エンドユーザー別(病院&クリニック、外来手術センター、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの内容を掲載しています。なお、当書には、Boston Scientific Corporation、Medtronic Plc、Cook Medical、Integra LifeSciences、CONMED Corporation、Privi Medical (Tracxn Technologies Limited)、Sklar Surgical Instrumentsなどの企業情報が含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の痔治療用デバイス市場規模:デバイス別
- バンド結紮装置の市場規模
- 硬化療法用インジェクターの市場規模
- 赤外線凝固装置の市場規模
- バイポーラプローブの市場規模
- その他デバイスの市場規模
・世界の痔治療用デバイス市場規模:エンドユーザー別
- 病院&クリニックにおける市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の痔治療用デバイス市場規模:地域別
- 北米の痔治療用デバイス市場規模
- ヨーロッパの痔治療用デバイス市場規模
- アジア太平洋の痔治療用デバイス市場規模
- 中南米の痔治療用デバイス市場規模
- 中東・アフリカの痔治療用デバイス市場規模
・競争状況

Hemorrhoid Treatment Devices Market – Scope of Report

TMR’s report on the global hemorrhoid treatment devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global hemorrhoid treatment devices market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hemorrhoid treatment devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the hemorrhoid treatment devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hemorrhoid treatment devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global hemorrhoid treatment devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hemorrhoid treatment devices market.

The report delves into the competitive landscape of the global hemorrhoid treatment devices market. Key players operating in the global hemorrhoid treatment devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global hemorrhoid treatment devices market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market hemorrhoid treatment devices.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemorrhoid Treatment Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hemorrhoid Treatment Devices Market Analysis and Forecasts, 2017 – 2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario Assessment
5.2. Technological Advancements
5.3. Pricing Analysis
5.4. COVID-19 Impact on Industry
6. Global Hemorrhoid Treatment Devices Market Analysis and Forecasts, By Device
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast By Device, 2017 – 2031
6.3.1. Band Ligators
6.3.1.1. Endoscopic Ligators
6.3.1.2. Non-endoscopic Ligators
6.3.2. Sclerotherapy Injectors
6.3.3. Infrared Coagulators
6.3.4. Bipolar Probes
6.3.5. Cryotherapy Devices
6.3.6. Hemorrhoid Laser Probes
6.3.7. Others
6.4. Market Attractiveness By Device
7. Global Hemorrhoid Treatment Devices Market Analysis and Forecasts, By End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast By End-user, 2017 – 2031
7.3.1. Hospitals & Clinics
7.3.2. Ambulatory Surgical Centers
7.3.3. Others
7.4. Market Attractiveness By End-user
8. Global Hemorrhoid Treatment Devices Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness By Country/Region
9. North America Hemorrhoid Treatment Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Device, 2017 – 2031
9.2.1. Band Ligators
9.2.1.1. Endoscopic Ligators
9.2.1.2. Non-endoscopic Ligators
9.2.2. Sclerotherapy Injectors
9.2.3. Infrared Coagulators
9.2.4. Bipolar Probes
9.2.5. Cryotherapy Devices
9.2.6. Hemorrhoid Laser Probes
9.2.7. Others
9.3. Market Value Forecast By End-user, 2017 – 2031
9.3.1. Hospitals & Clinics
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Market Value Forecast By Country, 2017 – 2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Device
9.5.2. By End-user
9.5.3. By Country
10. Europe Hemorrhoid Treatment Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Device, 2017 – 2031
10.2.1. Band Ligators
10.2.1.1. Endoscopic Ligators
10.2.1.2. Non-endoscopic Ligators
10.2.2. Sclerotherapy Injectors
10.2.3. Infrared Coagulators
10.2.4. Bipolar Probes
10.2.5. Cryotherapy Devices
10.2.6. Hemorrhoid Laser Probes
10.2.7. Others
10.3. Market Value Forecast By End-user, 2017 – 2031
10.3.1. Hospitals & Clinics
10.3.2. Ambulatory Surgical Centers
10.3.3. Others
10.4. Market Value Forecast By Country, 2017 – 2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Device
10.5.2. By End-user
10.5.3. By Country
11. Asia Pacific Hemorrhoid Treatment Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Device, 2017 – 2031
11.2.1. Band Ligators
11.2.1.1. Endoscopic Ligators
11.2.1.2. Non-endoscopic Ligators
11.2.2. Sclerotherapy Injectors
11.2.3. Infrared Coagulators
11.2.4. Bipolar Probes
11.2.5. Cryotherapy Devices
11.2.6. Hemorrhoid Laser Probes
11.2.7. Others
11.3. Market Value Forecast By End-user, 2017 – 2031
11.3.1. Hospitals & Clinics
11.3.2. Ambulatory Surgical Centers
11.3.3. Others
11.4. Market Value Forecast By Country, 2017 – 2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Device
11.5.2. By End-user
11.5.3. By Country
12. Latin America Hemorrhoid Treatment Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Device, 2017 – 2031
12.2.1. Band Ligators
12.2.1.1. Endoscopic Ligators
12.2.1.2. Non-endoscopic Ligators
12.2.2. Sclerotherapy Injectors
12.2.3. Infrared Coagulators
12.2.4. Bipolar Probes
12.2.5. Cryotherapy Devices
12.2.6. Hemorrhoid Laser Probes
12.2.7. Others
12.3. Market Value Forecast By End-user, 2017 – 2031
12.3.1. Hospitals & Clinics
12.3.2. Ambulatory Surgical Centers
12.3.3. Others
12.4. Market Value Forecast By Country, 2017 – 2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Device
12.5.2. By End-user
12.5.3. By Country
13. Middle East & Africa Hemorrhoid Treatment Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Device, 2017 – 2031
13.2.1. Band Ligators
13.2.1.1. Endoscopic Ligators
13.2.1.2. Non-endoscopic Ligators
13.2.2. Sclerotherapy Injectors
13.2.3. Infrared Coagulators
13.2.4. Bipolar Probes
13.2.5. Cryotherapy Devices
13.2.6. Hemorrhoid Laser Probes
13.2.7. Others
13.3. Market Value Forecast By End-user, 2017 – 2031
13.3.1. Hospitals & Clinics
13.3.2. Ambulatory Surgical Centers
13.3.3. Others
13.4. Market Value Forecast By Country, 2017 – 2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Device
13.5.2. By End-user
13.5.3. By Country
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2021)
14.3. Company Profiles
14.3.1. Boston Scientific Corporation
14.3.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Cook Medical
14.3.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Medtronic Plc
14.3.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Integra LifeSciences
14.3.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. CONMED Corporation
14.3.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Sklar Surgical Instruments
14.3.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Privi Medical (Tracxn Technologies Limited)
14.3.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview

List of Tables

Table 01: Global Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031

Table 02: Global Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Band Ligators, 2017–2031

Table 03: Global Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031

Table 07: North America Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Band Ligators, 2017–2031

Table 08: North America Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031

Table 11: Europe Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Band Ligators, 2017–2031

Table 12: Europe Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031

Table 15: Asia Pacific Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Band Ligators, 2017–2031

Table 16: Asia Pacific Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031

Table 19: Latin America Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Band Ligators, 2017–2031

Table 20: Latin America Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031

Table 23: Middle East & Africa Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by Band Ligators, 2017–2031

Table 24: Middle East & Africa Hemorrhoid Treatment Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031